“…However, most caffeine phenotyping studies have reported no bimodal distribution, and 2% to 10% of the study subjects appeared to have low xanthine oxidase activity (and therefore apparently poor metabolizers). 6,8,9,11,17 Nevertheless, xanthinuria is thought to be a rare disease, 27,41 whereas only one third of the persons with low xanthine oxidase activity have clinical symptoms referable to deficiency of xanthine oxidase or xanthine dehydrogenase. 27,41 Three mutations in the human xanthine dehydrogenase gene responsible for classic xanthinuria have been identified, 28,43 and other genotypical abnormalities have been reported for atypical type I xanthinuria or type II xanthinuria.…”